In March, the states Public Employee Insurance Agency (PEIA) decided it could no longer bear the crushing costs of Wegovy and Zepbound
7 Lastly, investigational agents hold promise for new anti-obesity therapies that may sustain weight loss or minimize weight regain
Understanding Telogen Effluvium Telogen effluvium occurs when a major stressor to the body causes hairs in the resting phase to fall out simultaneously
Should I meal prep before starting GLP-1 medication
Obstructive Sleep Apnea SURMOUNT-OSA trials investigated GLP2 in adults with moderate-to-severe obstructive sleep apnea and obesity: Significant improvements in apnea-hypopnea index (AHI) from baseline Benefits observed in participants both using and not using positive airway pressure therapy Improvements correlated with weight reduction FDA approval granted in December 2024 for moderate-to-severe OSA treatment Diabetes Prevention Extended follow-up from SURMOUNT-1 assessed diabetes prevention in participants with prediabetes: 94% reduction in progression to type 2 diabetes compared to placebo over 3 years Nearly all participants with prediabetes at baseline converted to normoglycemia Effects diminished during off-treatment follow-up period, indicating ongoing treatment benefit [CALLOUT BOX Highlighted] Important Context: While GLP2 has demonstrated substantial efficacy in multiple large-scale clinical trials, the majority of data comes from industry-sponsored studies with relatively short follow-up periods (40-72 weeks for most trials)
Includes pharmaceutical-grade GLP-1 medication (semaglutide), comprehensive medical consultation, injection training and all supplies, basic nutritional guidance, and follow-up scheduling
